TTR and cardiac amyloidosis: In postmortem studies (2, 3), cardiac amyloidosis (CA), especially “wild-type transthyretin” (ATTRwt), has shown a prevalence rate ranging from 22% to 25% in people older than 80 years, with a predominance for male patients.